Skip to content

Clinical trials

Phase 2 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 2 Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20031
20042
20054
20065
20072
20087
20096
20104
20118
201210
20136
20149
20151
201610
20175
20183
20196
20205
20211
20223
20236
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Recruiting13
Terminated9
Withdrawn9
Active, not recruiting4
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University10
Forest Laboratories5
University of North Carolina, Chapel Hill5
Holland Bloorview Kids Rehabilitation Hospital4
National Institute of Mental Health (NIMH)4
Arizona State University3
Neuren Pharmaceuticals Limited3
Seaside Therapeutics, Inc.3
Assistance Publique - Hôpitaux de Paris2
Drexel University College of Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder118
Autism Spectrum Disorder59
Asperger Syndrome14
Child Development Disorders, Pervasive13
Anxiety Disorders7
Fragile X Syndrome7
Epilepsy4
Neurodevelopmental Disorders3
Rett Syndrome3
Tuberous Sclerosis3

Trials

Showing 76 to 100 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.